Literature DB >> 12601661

Development of the Key Behaviors Change Inventory: a traumatic brain injury behavioral outcome assessment instrument.

Brent P Kolitz1, Rodney D Vanderploeg, Glenn Curtiss.   

Abstract

OBJECTIVE: To describe the development and initial validation of a neurobehavioral outcome measure, the Key Behaviors Change Inventory (KBCI), for individuals with traumatic brain injury (TBI).
DESIGN: Scale construction and development, and validity study.
SETTING: Large state university and postal survey. PARTICIPANTS: Seventy-five volunteer undergraduate students and 25 volunteer collateral informants of individuals with TBI participated in the item-analysis phase. Thirty members of the Brain Injury Association and 20 members of the National Multiple Sclerosis Society rated both an identified patient and an age- and gender-equated control in the validation phase.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Content validity was examined through expert panel item sorts. Scale internal consistencies were examined with the Cronbach alpha. Construct validity was examined by comparing scale elevations between controls and 2 neurologic groups.
RESULTS: Item-analysis procedures resulted in 8 scales of 8 items each: inattention, impulsivity, unawareness of problems, apathy, interpersonal difficulties, communication problems, somatic difficulties, and emotional adjustment. Internal consistency reliability coefficients ranged from.82 to.91. Multivariate analysis of variance revealed significant (P</=.001) differences in scale elevations among TBI, multiple sclerosis (MS), and control groups. The TBI and MS groups scored significantly higher than the control group on all scales; a subset of KBCI scales discriminated between the 2 neurologic groups.
CONCLUSION: The KBCI was both sensitive and specific to typical behavioral changes after TBI, thus supporting its usefulness in rehabilitation settings. Cross-validation and development of a normative database are future steps necessary in its development.

Entities:  

Mesh:

Year:  2003        PMID: 12601661     DOI: 10.1053/apmr.2003.50100

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  6 in total

Review 1.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

2.  The Italian version of the Brain Injury Rehabilitation Trust (BIRT) personality questionnaires: five new measures of personality change after acquired brain injury.

Authors:  Benedetta Basagni; Eduardo Navarrete; Debora Bertoni; Charlotte Cattran; Daniela Mapelli; Michael Oddy; Antonio De Tanti
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

3.  Multidimensional evaluation of prosthetically rehabilitated\cranial defects using key behavior change inventory.

Authors:  Thiruvalluvan Nagarajan; Poonam Prakash; Sujit Kumar Bhandari
Journal:  J Indian Prosthodont Soc       Date:  2021 Jul-Sep

Review 4.  Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.

Authors:  Laura N Gitlin; Katherine A Marx; Ian H Stanley; Bryan R Hansen; Kimberly S Van Haitsma
Journal:  Int Psychogeriatr       Date:  2014-08-06       Impact factor: 3.878

Review 5.  Traumatic Brain Injuries during Development: Implications for Alcohol Abuse.

Authors:  Zachary M Weil; Kate Karelina
Journal:  Front Behav Neurosci       Date:  2017-07-20       Impact factor: 3.558

Review 6.  Animal models to improve our understanding and treatment of suicidal behavior.

Authors:  T D Gould; P Georgiou; L A Brenner; L Brundin; A Can; P Courtet; Z R Donaldson; Y Dwivedi; S Guillaume; I I Gottesman; S Kanekar; C A Lowry; P F Renshaw; D Rujescu; E G Smith; G Turecki; P Zanos; C A Zarate; P A Zunszain; T T Postolache
Journal:  Transl Psychiatry       Date:  2017-04-11       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.